FSH vs Kisspeptin-10

Binds FSH receptors on Sertoli cells in testes to support sperm maturation and inhibin B production. In women, binds granulosa cell FSH receptors to drive follicular growth and estradiol production.

FSH (follicle-stimulating hormone) is an endogenous heterodimeric glycoprotein hormone produced and secreted by pituitary gonadotrophs, composed of a non-covalently associated common alpha subunit shared with LH, TSH, and hCG, and a unique FSH-specific beta subunit that confers receptor specificity; it is the primary regulator of gametogenesis in both sexes, acting on ovarian granulosa cells and testicular Sertoli cells to drive reproductive development. FSH activates its cognate receptor (FSHR) through cAMP-mediated signaling to stimulate follicular maturation and estradiol synthesis in the ovary via aromatase upregulation, and to support spermatogenesis in the testis by promoting Sertoli cell function and germ cell proliferation; FSH levels rise dramatically at menopause as negative feedback from ovarian estrogen declines. A Cochrane systematic review and meta-analysis established that recombinant FSH preparations are clinically equivalent to urinary-derived gonadotropins for ovarian stimulation in assisted reproductive technology cycles, providing the evidence base underlying current ART practice; this review supports the use of recombinant FSH as the standard of care for controlled ovarian hyperstimulation. FDA-approved recombinant FSH preparations — follitropin alfa (Gonal-f) and follitropin beta (Follistim) — require a prescription and are indicated for ovulation induction and ART in women and for hypogonadotropic hypogonadism in men; endogenous FSH is not administered as a therapeutic agent, and research-grade recombinant FSH is used as a cell culture tool and reproductive biology research compound.

Activates GPR54/KISS1R receptor on GnRH neurons; triggers pulsatile GnRH release → LH/FSH surge → testosterone/estrogen production

Kisspeptin-10 is a 10-amino-acid C-terminal fragment of the KISS1-derived peptide family, which serves as the primary upstream regulator of GnRH pulsatility in the hypothalamus. By binding to the KISS1R receptor on GnRH neurons, kisspeptin-10 triggers GnRH release and downstream LH and FSH secretion, positioning it as a master regulator of the reproductive neuroendocrine axis. Peer-reviewed human studies demonstrate that kisspeptin administration evokes LH pulse generation and modulates gonadotropin secretion in both healthy volunteers and individuals with reproductive dysfunction, including polycystic ovary syndrome. Kisspeptin-10 is an investigational peptide actively studied in clinical research; it is not approved by the FDA for any therapeutic indication and is not available as a licensed pharmaceutical. Kisspeptin-10 research contexts: clinical studies at Imperial College London and other institutions have characterized kisspeptin-10 pharmacology in human subjects across multiple reproductive contexts. In women, kisspeptin administration has been studied for ovulation triggering in IVF protocols as an alternative to hCG, with phase 2 trial data supporting its effectiveness for oocyte maturation while potentially reducing ovarian hyperstimulation syndrome risk. In men with hypogonadotropic hypogonadism, kisspeptin-10 infusion protocols have been studied to characterize LH pulse deficits and assess reproductive axis recovery. The peptide's upstream position in the GnRH axis — above gonadorelin, hCG, and downstream gonadotropins — makes it a research tool for understanding the root causes of hypothalamic-level reproductive dysfunction. Kisspeptin-10 vs kisspeptin-54: the two forms differ in length and pharmacokinetic profile. Kisspeptin-54 is the full 54-amino-acid peptide with a longer half-life in circulation; kisspeptin-10 is the truncated, most biologically active fragment. Human studies have used both forms depending on the research objective — kisspeptin-10 for acute LH pulse characterization, kisspeptin-54 for sustained gonadotropin studies. Neither is commercially available as an approved therapeutic. Fertility-focused telehealth providers and reproductive hormone specialists are listed in the PeptideBase directory.